TIM‐1 Signaling Is Required for Maintenance and Induction of Regulatory B Cells

Apart from their role in humoral immunity, B cells can exhibit IL‐10‐dependent regulatory activity (Bregs). These regulatory subpopulations have been shown to inhibit inflammation and allograft rejection. However, our understanding of Bregs has been hampered by their rarity, lack of a specific marker, and poor insight into their induction and maintenance. We previously demonstrated that T cell immunoglobulin mucin domain‐1 (TIM‐1) identifies over 70% of IL‐10‐producing B cells, irrespective of other markers. We now show that TIM‐1 is the primary receptor responsible for Breg induction by apoptotic cells (ACs). However, B cells that express a mutant form of TIM‐1 lacking the mucin domain (TIM‐1Δmucin) exhibit decreased phosphatidylserine binding and are unable to produce IL‐10 in response to ACs or by specific ligation with anti‐TIM‐1. TIM‐1Δmucin mice also exhibit accelerated allograft rejection, which appears to be due in part to their defect in both baseline and induced IL‐10+ Bregs, since a single transfer of WT TIM‐1+ B cells can restore long‐term graft survival. These data suggest that TIM‐1 signaling plays a direct role in Breg maintenance and induction both under physiological conditions (in response to ACs) and in response to therapy through TIM‐1 ligation. Moreover, they directly demonstrate that the mucin domain regulates TIM‐1 signaling.

• Publication year

  2015

• Venue

  American Journal of Transplantation

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/ajt.13087PMID 25645598PMCID PMC4530122
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-35 Induces Regulatory B Cells that Suppress CNS Autoimmune Disease

  2014cited by this paper
• TIM-1 glycoprotein binds the adhesion receptor P-selectin and mediates T cell trafficking during inflammation and autoimmunity.

  2014cited by this paper
• IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases

  2014cited by this paper
• Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion.

  2013cited by this paper
• Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice

  2012influential reference
• Orphan nuclear receptor Nur77 promotes acute kidney injury and renal epithelial apoptosis.

  2012cited by this paper
• Immune regulatory function of B cells.

  2012cited by this paper
• A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells

  2011influential reference
• Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice.

  2011influential reference
• Two-Step Engulfment of Apoptotic Cells

  2011cited by this paper
• Natural IgM Is Required for Suppression of Inflammatory Arthritis by Apoptotic Cells

  2011cited by this paper
• TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity

  2010cited by this paper
• B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer

  2010cited by this paper
• The phosphatidylserine receptor TIM-4 does not mediate direct signaling.

  2009cited by this paper
• The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model.

  2008cited by this paper
• A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses.

  2008cited by this paper
• New roles for TIM family members in immune regulation

  2008cited by this paper
• Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells.

  2008cited by this paper
• Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice.

  2008influential reference
• Engulfment of apoptotic cells: signals for a good meal

  2007cited by this paper
• Structures of T Cell Immunoglobulin Mucin Receptors 1 and 2 Reveal Mechanisms for Regulation of Immune Responses by the TIM Receptor Family

  2007cited by this paper
• TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells.

  2007cited by this paper
• Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function

  2007influential reference
• Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells

  2007influential reference
• Allograft Rejection in a New Allospecific CD4+ TCR Transgenic Mouse

  2003cited by this paper
• Physiological Mechanisms of Regulating Alloimmunity: Cytokines, CTLA-4, CD25+ Cells, and the Alloreactive T Cell Clone Size1

  2002cited by this paper
• B cells regulate autoimmunity by provision of IL-10

  2002cited by this paper
• Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family

  2001cited by this paper

• Regulatory B Cells in Tumor Microenvironment

  2026cites this paper
• Integrating Novel Biomarkers into Clinical Practice: A Practical Framework for Diagnosis and Management of Cardiorenal Syndrome

  2025cites this paper
• Distribution characteristics and prognostic value of TIM-1 in patients with lung adenocarcinoma

  2025cites this paper
• Emerging roles of checkpoint molecules on B cells

  2025cites this paper
• B-cell subsets have different capacities for phagocytosis and subsequent presentation of antigen to cognate T cells.

  2025cites this paper
• Regulatory B cells: changing the landscape of immunoregulation and immunotherapy.

  2025cites this paper
• Immunomodulation by allograft endothelial cells

  2025cites this paper
• Multiple functions of HMGB1 in cancer

  2024cites this paper
• Sensing Dying Cells in Health and Disease

  2024cites this paper
• B Cell–mediated Immune Regulation and the Quest for Transplantation Tolerance

  2024cites this paper
• TIM proteins and microRNAs: distinct impact and promising interactions on transplantation immunity

  2024cites this paper
• Regulatory B cells in autoimmune diseases: Insights and therapeutic potential.

  2024cites this paper
• Expanding Human Breg for Cellular Therapy in Transplantation: Time for Translation

  2024cites this paper
• The current understanding of the phenotypic and functional properties of human regulatory B cells (Bregs)

  2024cites this paper
• Inhibition of the TIM-1 and -3 Signaling Pathway Ameliorates Disease in a Murine Model of Rheumatoid Arthritis.

  2024cites this paper
• Elevated Serum KIM-1 in Sepsis Correlates with Kidney Dysfunction and the Severity of Multi-Organ Critical Illness

  2024cites this paper
• B-cell-specific checkpoint molecules that regulate anti-tumour immunity

  2023cites this paper
• Regulatory B Cells in Solid Organ Transplantation: From Immune Monitoring to Immunotherapy

  2023cites this paper
• B cells: The many facets of B cells in allergic diseases.

  2023cites this paper
• Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis

  2022cites this paper
• The Regulation between CD4+CXCR5+ Follicular Helper T (Tfh) Cells and CD19+CD24hiCD38hi Regulatory B (Breg) Cells in Gastric Cancer

  2022cites this paper
• Regulatory and transitional B cells: potential biomarkers and therapeutic targets in organ transplantation

  2022cites this paper
• B regulatory cells in patients with autoimmune diseases: Pathogenic significance and therapeutic potential

  2022cites this paper
• Immunosuppressive Mechanisms of Regulatory B Cells

  2021cites this paper
• Regulatory B cells: TIM‐1, transplant tolerance, and rejection

  2021cites this paper
• Characterization and Activity of TIM-1 and IL-10-Reporter Expressing Regulatory B Cells.

  2021cites this paper
• Altered Tim-1 and IL-10 Expression in Regulatory B Cell Subsets in Type 1 Diabetes

  2021cites this paper
• Towards regulatory cellular therapies in solid organ transplantation.

  2021cites this paper
• Diverse roles of immune cells in transplant rejection and immune tolerance

  2021cites this paper
• Novel Roles of the Tim Family in Immune Regulation and Autoimmune Diseases

  2021cites this paper
• Regulation of Alloantibody Responses

  2021cites this paper
• The neglected brothers come of age: B cells and cancer.

  2021cites this paper
• The Role of Regulatory B cells in Kidney Diseases

  2021cites this paper
• Regulatory B cells, A to Z

  2021cites this paper
• Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease

  2020cites this paper
• Checkpoint Receptor TIGIT Expressed on Tim-1+ B Cells Regulates Tissue Inflammation.

  2020cites this paper
• TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy

  2020cites this paper
• CD19+CD24hiCD38hi B Cell Dysfunction in Primary Biliary Cholangitis

  2020cites this paper
• CD19CD24CD38 B Cell Dysfunction in Primary Biliary Cholangitis

  2020cites this paper
• Toll-Like Receptor Signaling and Immune Regulatory Lymphocytes in Periodontal Disease

  2020cites this paper
• B regulatory cells in allergy

  2020cites this paper
• Strategies to achieve immune tolerance in allogeneic solid organ transplantation.

  2020cites this paper
• IL-4 REGULATES THE SECRETION OF IL-10 BY HUMAN B CELLS

  2020cites this paper
• Regulatory B cells in transplantation: roadmaps to clinic

  2020influential citation
• Costimulation Blockade in Transplantation.

  2019cites this paper
• Regulatory and Effector B Cells: A New Path Toward Biomarkers and Therapeutic Targets to Improve Transplant Outcomes?

  2019cites this paper
• The pursuit of transplantation tolerance: new mechanistic insights

  2019cites this paper
• Understanding kidney injury molecule 1: a novel immune factor in kidney pathophysiology.

  2019cites this paper
• Cell Therapy in Solid Organ Transplantation.

  2019cites this paper
• Anti-CD45RB Antibody Therapy Attenuates Renal Ischemia-Reperfusion Injury by Inducing Regulatory B Cells.

  2019cites this paper
• An update on potentials and promises of T cell co‐signaling molecules in transplantation

  2019cites this paper
• Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation.

  2019cites this paper
• Regulatory B cells and transplantation: almost prime time?

  2018cites this paper
• Identification of the Subsets of IL-10-Producing Regulatory B Cells in the Course of Tolerance Induction and Maintenance in Islet Allotransplantation.

  2018cites this paper
• Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion

  2018cites this paper
• CD27+TIM-1+ memory B cells promoted the development of Foxp3+ Tregs and were associated with better survival in acute respiratory distress syndrome

  2018cites this paper
• The regulatory roles of B cell subsets in transplantation

  2018cites this paper
• Regulatory B cells: the cutting edge of immune tolerance in kidney transplantation

  2018cites this paper
• Phenotypes, Origins and Functions of Regulatory B Cells in Autoimmune and Inflammatory Diseases

  2018cites this paper
• Bacterially activated B‐cells drive T cell differentiation towards Tr1 through PD‐1/PD‐L1 expression

  2018cites this paper
• CD27+TIM-1+ memory B cells promoted the development of Foxp3+ Tregs and were associated with better survival in acute respiratory distress syndrome

  2018cites this paper
• Liposomes as colloidal nanovehicles: on the road to success in intravenous drug delivery

  2017cites this paper
• Regulatory B Cells in Pregnancy: Lessons from Autoimmunity, Graft Tolerance, and Cancer

  2017cites this paper
• Microbial infection and mechanisms of intestinal inflammation

  2017cites this paper
• This information is current as Promote Tumor and Allograft Rejection Proinflammatory B Effector 1 Cells That Expressing − γ TIM-4 Identifies IFN

  2017cites this paper
• Influence of drug molecules on regulatory B cells.

  2017cites this paper
• TIM-4 Identifies IFN-γ–Expressing Proinflammatory B Effector 1 Cells That Promote Tumor and Allograft Rejection

  2017cites this paper
• Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis

  2017cites this paper
• IL-21/anti-Tim1/CD40 ligand promotes B10 activity in vitro and alleviates bone loss in experimental periodontitis in vivo.

  2017cites this paper
• Blood biomarkers of kidney transplant rejection, an endless search?

  2017cites this paper
• Phosphatidylserine Outer Layer Translocation Is Implicated in IL-10 Secretion by Human Regulatory B Cells

  2017cites this paper
• TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients

  2017cites this paper
• Transplantation tolerance: don't forget about the B cells

  2017cites this paper
• Use of polyclonal/monoclonal antibody therapies in transplantation

  2017cites this paper
• Regulatory B cells: Phenotype, function and role in transplantation.

  2017cites this paper
• Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies

  2016cites this paper
• T Cell Cosignaling Molecules in Transplantation.

  2016cites this paper
• Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis.

  2016cites this paper
• Inflammation Causes Resistance to Anti‐CD20–Mediated B Cell Depletion

  2016cites this paper
• Kidney Injury Molecule-1 Is Specifically Expressed in Cystically-Transformed Proximal Tubules of the PKD/Mhm (cy/+) Rat Model of Polycystic Kidney Disease

  2016cites this paper
• CD19+ Tim-1+ B cells are decreased and negatively correlated with disease severity in Myasthenia Gravis patients

  2016cites this paper
• Regulation of mast cell function by TIM-1 and TIM-3 signaling

  2016influential citation
• Caractérisation des lymphocytes B régulateurs dans la leucémie lymphoïde chronique

  2016influential citation
• Development of a Novel Antibody–Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1

  2016cites this paper
• Tracing Donor-MHC Class II Reactive B cells in Mouse Cardiac Transplantation: Delayed CTLA4-Ig Treatment Prevents Memory Alloreactive B-Cell Generation

  2016cites this paper
• G protein α12 (Gα12) is a negative regulator of kidney injury molecule-1-mediated efferocytosis.

  2016cites this paper
• CD19+ Tim-1+ B cells are decreased and negatively correlated with disease severity in Myasthenia Gravis patients

  2016cites this paper
• Kidney Injury Molecule-1 Signalling in Ischemic Acute Kidney Injury and Phagocytosis

  2015influential citation
• Diversity of gut microflora is required for the generation of B cell with regulatory properties in a skin graft model

  2015cites this paper
• The expanding family of regulatory B cells

  2015cites this paper
• Exploring cell-based tolerance strategies for hand and face transplantation

  2015cites this paper
• Introduction: Regulatory B Cell Special Issue-making all the pieces fit.

  2015cites this paper
• Role of B cells in tolerance induction

  2015cites this paper
• Monitoring B cell subsets and alloreactivity in kidney transplantation.

  2015cites this paper